Explain this page
Arphra AIPlain-English read on Replimune Group, Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $14.00 (+55.47%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.39% | -10.22% | +121.25% | +4.35% | -12.57% | -7.36% | -11.54% | -59.92% | -72.79% | -40.60% | -40.60% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$110.88K
1 txn
Net flow
−$110.88K
Aftermarket
LiveLast trade
$9.01
11 sh
Bid
$9.00
200 sh
Ask
$9.02
342 sh
Spread
$0.020
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Communication Services+0.40%
- Financial Services+0.18%
- Energy+0.01%
- Technology-0.07%
- Consumer Cyclical-0.13%
- Consumer Defensive-0.45%
- Healthcare-0.50%
- Industrials-0.73%
- Basic Materials-1.36%
- Utilities-1.53%
- Real Estate-1.58%
Top industries (issuer's industry highlighted)
- Biotechnology+0.81%
- Electronic Gaming & Multimedia+3.97%
- Investment - Banking & Investment Services-2.87%
- Financial - Mortgages+2.35%
- Furnishings, Fixtures & Appliances+2.05%
- Coal-1.99%
- Chemicals-1.98%
- Solar-1.95%
- Medical - Healthcare Information Services+1.92%
- Travel Services+1.69%
- Gambling, Resorts & Casinos+1.65%
- Apparel - Footwear & Accessories+1.57%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Replimune: Perhaps The FDA Shakeup Will Get A Mulligan For RP1seekingalpha.com·May 13, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Replimune Group, Inc. – REPLglobenewswire.com·May 12, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Replimune Group, Inc. – REPLglobenewswire.com·May 12, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPLprnewswire.com·May 07, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPLprnewswire.com·Apr 30, 2026
Peers
No peer list available for REPL.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Sarchi Christopher officer: Chief Commercial Officer | Sell | 12,000 | $110.88K | Jun 01, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|